Home · Briefings

Briefing 05 · After · 4 min read

Leaving a study, and what happens after

Taking part is voluntary from start to finish. Here is what leaving looks like, why some follow-up still matters, and how results find their way back.

Key takeaways

  • You can withdraw at any time, for any reason, without losing the medical care you would normally receive.
  • Teams may ask about a final safety visit, and about data already collected.
  • Many studies share results publicly, though timing varies.

You can always stop

Withdrawing is a right written into the consent process. You do not owe an explanation, and leaving does not change your regular care. Tell the study team so they can walk you through any safe steps, such as how to stop a study medicine and whether to schedule a final check.

Why a final visit may be suggested

If you are taking a study treatment, stopping suddenly is not always the safest way. A final visit lets the team check on you. You can say no to it, too, but it is worth hearing why they ask.

What happens to your data

Information already collected usually stays in the study, because removing it could affect the results. The consent form explains how identifiers are protected and what happens to stored samples. Ask before you sign if you want to know whether you can request deletion.

How results are shared

Many studies post summary results on public registries such as ClinicalTrials.gov, and publish papers. Some teams send participants a plain-language summary. If you want one, ask at the beginning.

General information only. This briefing is not medical, legal, or financial advice, and Trialuma is not a medical provider. Talk with your own doctor about your health.

Next step

Keep the briefings close.

Tell us what you’d like to read about. It’s free, there’s no obligation, and you can opt out of texts any time by replying STOP.

Get the briefings